CCR Innovations | Volume 2 | Issue 1 - page 8

8
California Cancer Registry
Volume 2, Issue 1
Meaningful Use Stage 2
(Cont. Pg 9)
Preparations for Meaningful Use (MU) Stage 2 are now underway at the California Department of Public
Health (CDPH). There is a lot of complex information available outlining what MU is and how Cancer
Reporting is included. Let’s take a step back and outline the concept of MU. MU is based on the five
priorities of health outcomes policy:
Improving quality, safety, efficiency, and reducing health disparities
Engage patients and families in their health
Improve care coordination
Improve population and public health
Ensure adequate privacy and security protection for personal health information
These improvements to our healthcare system are based on the use of EHR systems throughout all
practices and hospitals. A set of requirements were outlined by the MU Public Health Objectives of the
Centers for Medicare and Medicaid Services (CMS) Electronic Health Record (EHR) Incentive Program to
ensure that providers and hospitals are using their EHR technology to help meet the five priorities outlined
above. Included in these requirements is sending data to public health agencies, which is MU Stage 2.
In preparation for MU Stage 2, the CDPH Meaningful Use Team has launched the
website. This site will allow eligible healthcare professionals and hospitals to
securely register and manage data submissions to the CDPH. For cancer case reporting:
Only physician offices
reporting for MU Stage 2
need to register their intent
to send
data through the HIE Gateway. The California Cancer Registry (CCR) will be able to
receive MU Stage 2 data from physician offices by
January 1, 2014
.
Current entities reporting cancer cases
to CCR that are not part of MU Stage 2 do not
need to register intent with the HIE Gateway at this time. Current entities reporting
cancer cases to CCR are to continue to report through the existing system.
The inclusion of cancer reporting in MU will prove to be a great resource in collecting data for cases where
patients receive their cancer treatment in an outpatient setting. The automation of this type of reporting
will help ensure that all cases are accounted for in the Eureka database.
To regulate the data received from physician’s offices, the Centers for Disease Control and Prevention
(CDC)/National Program of Cancer Registries (NPCR) collaborated with North American Association of
Central Cancer Registries (NAACCR), central cancer registries nationwide, clinicians, EHR vendors, and
other partners to develop the
Implementation Guide for Ambulatory Healthcare Provider Reporting to
Central Cancer Registries.
This guide standardizes data transmissions from a healthcare provider EHR using
Health Level Seven Clinical Document Architecture (HL7 CDA) based standards. It provides business rules
and specifications to:
Identify reportable cancer cases
Identify the specific data elements to be retrieved and included in the cancer event report
1,2,3,4,5,6,7 9,10,11,12,13,14